1:2:1 Podcast

Sharon Perry on treating TB in N. Korea

A team of Stanford specialists recently returned from North Korea, where they are working to develop the country's first diagnostic laboratory to test drug-resistant tuberculosis. Without these services, considered standard of care in the West, only about 50 percent of TB is detected, and the types of drugs needed to effectively treat the disease cannot be determined. Launched in 2008, the TB Diagnostics Project is being led by the Bay Area TB Consortium and the Nuclear Threat Initiative, a Washington nonprofit group working to strengthen global security. In this podcast, Sharon Perry, PhD, director of the consortium and senior research scientist from the school's division of infectious diseases, discusses the new laboratory and how it will fill a critical gap in North Korea’s TB control program and help eradicate the disease.

Length: 19 mins. 21 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.